|
1
|
Collins AJ, Foley RN, Gilbertson DT and
Chen SC: The state of chronic kidney disease, ESRD, and morbidity
and mortality in the first year of dialysis. Clin J Am Soc Nephrol.
4(Suppl 1): S5–S11. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Mandayam S and Shahinian VB: Are chronic
dialysis patients at increased risk for cancer? J Nephrol.
21:166–174. 2008.PubMed/NCBI
|
|
3
|
Briggs JD: Causes of death after renal
transplantation. Nephrol Dial Transplant. 16:1545–1549. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Vajdic CM, McDonald SP, McCredie MR, van
Leeuwen MT, Stewart JH, Law M, Chapman JR, Webster AC, Kaldor JM
and Grulich AE: Cancer incidence before and after kidney
transplantation. JAMA. 296:2823–2831. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Penn I and Starzl TE: Malignant lymphomas
in transplantation patients: A review of the world experience. Int
J Clin Pharmacol Ther Toxicol. 3:49–54. 1970.
|
|
6
|
Marple JT and MacDougall M: Development of
malignancy in the end-stage renal disease patient. Semin Nephrol.
13:306–314. 1993.PubMed/NCBI
|
|
7
|
Grulich AE, van Leeuwen MT, Falster MO and
Vajdic CM: Incidence of cancers in people with HIV/AIDS compared
with immunosuppressed transplant recipients: A meta-analysis.
Lancet. 370:59–67. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Stewart JH, Vajdic CM, van Leeuwen MT,
Amin J, Webster AC, Chapman JR, McDonald SP, Grulich AE and
McCredie MR: The pattern of excess cancer in dialysis and
transplantation. Nephrol Dial Transplant. 24:3225–3231. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lin HF, Li YH, Wang CH, Chou CL, Kuo DJ
and Fang TC: Increased risk of cancer in chronic dialysis patients:
A population-based cohort study in Taiwan. Nephrol Dial Transplant.
27:1585–1590. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Loy EY, Choong HL and Chow KY: Cancer
among end-stage renal disease patients on dialysis. Ann Acad Med
Singapore. 42:640–645. 2013.PubMed/NCBI
|
|
11
|
Butler AM, Olshan AF, Kshirsagar AV,
Edwards JK, Nielsen ME, Wheeler SB and Brookhart MA: Cancer
incidence among US Medicare ESRD patients receiving hemodialysis,
1996–2009. Am J Kidney Dis. 65:763–772. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Collett D, Mumford L, Banner NR, Neuberger
J and Watson C: Comparison of the incidence of malignancy in
recipients of different types of organ: A UK registry audit. Am J
Transplant. 10:1889–1896. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Li WH, Chen YJ, Tseng WC, Lin MW, Chen TJ,
Chu SY, Hwang CY, Chen CC, Lee DD, Chang YT, et al: Malignancies
after renal transplantation in Taiwan: A nationwide
population-based study. Nephrol Dial Transplant. 27:833–839. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Cheung CY, Lam MF, Chu KH, Chow KM, Tsang
KY, Yuen SK, Wong PN, Chan SK, Leung KT, Chan CK, et al:
Malignancies after kidney transplantation: Hong Kong renal
registry. Am J Transplant. 12:3039–3046. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Piselli P, Serraino D, Segoloni GP, et al:
Risk of de novo cancers after transplantation: Results from
a cohort of 7217 kidney transplant recipients, Italy 1997–2009. Eur
J Cancer. 49:336–344. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Krynitz B, Edgren G, Lindelöf B, Baecklund
E, Brattström C, Wilczek H and Smedby KE: Risk of skin cancer and
other malignancies in kidney, liver, heart and lung transplant
recipients 1970 to 2008 - a Swedish population-based study. Int J
Cancer. 132:1429–1438. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Stengel B: Chronic kidney disease and
cancer: A troubling connection. J Nephrol. 23:253–262.
2010.PubMed/NCBI
|
|
18
|
Izzedine H and Perazella MA:
Onco-nephrology: An appraisal of the cancer and chronic kidney
disease links. Nephrol Dial Transplant. 30:1979–1988. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Moher D, Liberati A, Tetzlaff J and Altman
DG: PRISMA Group: Preferred reporting items for systematic reviews
and meta-analyses: The PRISMA statement. PLoS Med. 6:e10000972009.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Stang A: Critical evaluation of the
Newcastle-Ottawa scale for the assessment of the quality of
nonrandomized studies in meta-analyses. Eur J Epidemiol.
25:603–605. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Egger M, Smith Davey G, Schneider M and
Minder C: Bias in meta-analysis detected by a simple, graphical
test. BMJ. 315:629–634. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Port FK, Ragheb NE, Schwartz AG and
Hawthorne VM: Neoplasms in dialysis patients: A population-based
study. Am J Kidney Dis. 14:119–123. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Birkeland SA, Løkkegaard H and Storm HH:
Cancer risk in patients on dialysis and after renal
transplantation. Lancet. 355:1886–1887. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hoshida Y, Tsukuma H, Yasunaga Y, Xu N,
Fujita MQ, Satoh T, Ichikawa Y, Kurihara K, Imanishi M, Matsuno T
and Aozasa K: Cancer risk after renal transplantation in Japan. Int
J Cancer. 71:517–520. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kyllönen L, Salmela K and Pukkala E:
Cancer incidence in a kidney-transplanted population. Transpl Int.
13(Suppl 1): S394–S398. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Adami J, Gäbel H, Lindelöf B, Ekström K,
Rydh B, Glimelius B, Ekbom A, Adami HO and Granath F: Cancer risk
following organ transplantation: A nationwide cohort study in
Sweden. Br J Cancer. 89:1221–1227. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Végso G, Tóth M, Hídvégi M, Toronyi E,
Langer RM, Dinya E, Tóth A, Perner F and Járay J: Malignancies
after renal transplantation during 33 years at a single center.
Pathol Oncol Res. 13:63–69. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Villeneuve PJ, Schaubel DE, Fenton SS,
Shepherd FA, Jiang Y and Mao Y: Cancer incidence among Canadian
kidney transplant recipients. Am J Transplant. 7:941–948. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Serraino D, Piselli P, Busnach G, Burra P,
Citterio F, Arbustini E, Baccarani U, De Juli E, Pozzetto U,
Bellelli S, et al: Risk of cancer following immunosuppression in
organ transplant recipients and in HIV-positive individuals in
southern Europe. Eur J Cancer. 43:2117–2123. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Maisonneuve P, Agodoa L, Gellert R,
Stewart JH, Buccianti G, Lowenfels AB, Wolfe RA, Jones E, Disney
AP, Briggs D, et al: Cancer in patients on dialysis for end-stage
renal disease: An international collaborative study. Lancet.
354:93–99. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Yan L, Chen P, Chen EZ, Gu A and Jiang ZY:
Risk of bladder cancer in renal transplant recipients: A
meta-analysis. Br J Cancer. 110:1871–1877. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Yang Z, Lin F, Qin B, Liang Y and Zhong R:
Polymyositis/dermatomyositis and malignancy risk: A metaanalysis
study. J Rheumatol. 42:282–291. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Heidland A, Bahner U and Vamvakas S:
Incidence and spectrum of dialysis-associated cancer in three
continents. Am J Kidney Dis. 35:347–351; discussion 352–353. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Vamvakas S, Bahner U and Heidland A:
Cancer in end-stage renal disease: Potential factors
involved-editorial. Am J Nephrol. 18:89–95. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Engels EA, Pfeiffer RM, Fraumeni JF Jr,
Kasiske BL, Israni AK, Snyder JJ, Wolfe RA, Goodrich NP, Bayakly
AR, Clarke CA, et al: Spectrum of cancer risk among US solid organ
transplant recipients. JAMA. 306:1891–1901. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Marple JT, MacDougall M and Chonko AM:
Renal cancer complicating acquired cystic kidney disease. J Am Soc
Nephrol. 4:1951–1956. 1994.PubMed/NCBI
|
|
37
|
Taylor AE and Shuster S: Skin cancer after
renal transplantation: The causal role of azathioprine. Acta Derm
Venereol. 72:115–119. 1992.PubMed/NCBI
|
|
38
|
Silman AJ, Petrie J, Hazleman B and Evans
SJ: Lymphoproliferative cancer and other malignancy in patients
with rheumatoid arthritis treated with azathioprine: A 20 year
follow up study. Ann Rheum Dis. 47:988–992. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Vamvakas S, Bahner U, Becker P, Steinle A,
Götz R and Heidland A: Impairment of DNA repair in the course of
long-term hemodialysis and under cyclosporine immunosuppression
after renal transplantation. Transplant Proc. 28:3468–3473.
1996.PubMed/NCBI
|
|
40
|
Yoshimura S, Suemizu H, Nomoto Y, Sakai H,
Katsuoka Y, Kawamura N and Moriuchi T: Plasma glutathione
peroxidase deficiency caused by renal dysfunction. Nephron.
73:207–211. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Akizawa T, Kinugasa E and Koshikawa S:
Increased risk of malignancy and blood-membrane interactions in
uraemic patients. Nephrol Dial Transplant. 9(Suppl 2): S162–S164.
1994.
|
|
42
|
Gutierrez-Dalmau A and Campistol JM:
Immunosuppressive therapy and malignancy in organ transplant
recipients: A systematic review. Drugs. 67:1167–1198. 2007.
View Article : Google Scholar : PubMed/NCBI
|
